BMP2 Genetically Engineered MSCs and EPCs Promote Vascularized Bone Regeneration in Rat Critical-Sized Calvarial Bone Defects

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  He, Xiaoning ^a,b   Dziak, Rosemary ^a   Yuan, Xue ^a   Mao, Keya ^e   Genco, Robert ^a   Swihart, Mark ^c   Sarkar, Debanjan ^d   Li, Chunyi ^a   Wang, Changdong ^a   Lu, Li ^b   Andreadis, Stelios ^a,c,d   Yang, Shuying ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHINA MEDICAL UNIVERSITY   (China)

^c China Medical University ^*  (United States)

^d The State University of New York   (United States)

^e CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCIUM ALGINATE; CALCIUM SULFATE; MOLECULAR SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; CALVARIA; CELL DIFFERENTIATION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CRITICAL SIZED BONE DEFECT; DNA MODIFICATION; ENDOTHELIAL PROGENITOR CELL; GENETIC ENGINEERING; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; RAT; STEM CELL TRANSPLANTATION; VASCULARIZATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CELL SURVIVAL; ENDOTHELIAL CELLS; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOGENESIS; RATS; SKULL; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

RATTUS;

EID: 84875660876     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060473     Document Type: Article

References (66)

1. Gosain AK, Song L, Yu P, Mehrara BJ, Maeda CY, et al. (2000) Osteogenesis in cranial defects: reassessment of the concept of critical size and the expression of TGF-beta isoforms. Plast Reconstr Surg 106:360-371;discussion 372.
2. Janicki P, Schmidmaier G, (2011) What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells. Injury 42Suppl 2: S77-81.
3. Muschler GF, Matsukura Y, Nitto H, Boehm CA, Valdevit AD, et al. (2005) Selective retention of bone marrow-derived cells to enhance spinal fusion. Clin Orthop Relat Res: 242-251.
4. Bowers GM, Chadroff B, Carnevale R, Mellonig J, Corio R, et al. (1989) Histologic evaluation of new attachment apparatus formation in humans. Part III. J Periodontol 60: 683-693.
5. Laurell L, Gottlow J, Zybutz M, Persson R, (1998) Treatment of intrabony defects by different surgical procedures. A literature review. J Periodontol 69: 303-313.
6. Samstein B, Platt JL, (2001) Physiologic and immunologic hurdles to xenotransplantation. J Am Soc Nephrol 12: 182-193.
7. Eppley BL, Pietrzak WS, Blanton MW, (2005) Allograft and alloplastic bone substitutes: a review of science and technology for the craniomaxillofacial surgeon. J Craniofac Surg 16: 981-989.
8. Marcacci M, Kon E, Moukhachev V, Lavroukov A, Kutepov S, et al. (2007) Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 13: 947-955.
9. Korbling M, Estrov Z, (2003) Adult stem cells for tissue repair- a new therapeutic concept? N Engl J Med 349: 570-582.
10. Tai K, Pelled G, Sheyn D, Bershteyn A, Han L, et al. (2008) Nanobiomechanics of repair bone regenerated by genetically modified mesenchymal stem cells. Tissue Eng Part A 14: 1709-1720.
11. Tsuda H, Wada T, Yamashita T, Hamada H, (2005) Enhanced osteoinduction by mesenchymal stem cells transfected with a fiber-mutant adenoviral BMP2 gene. J Gene Med 7: 1322-1334.
12. Akita S, Fukui M, Nakagawa H, Fujii T, Akino K, (2004) Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Repair Regen 12: 252-259.
13. Eyckmans J, Luyten FP, (2006) Species specificity of ectopic bone formation using periosteum-derived mesenchymal progenitor cells. Tissue Eng 12: 2203-2213.
14. Streeten DH, (1990) Pathogenesis of hyperadrenergic orthostatic hypotension. Evidence of disordered venous innervation exclusively in the lower limbs. J Clin Invest 86: 1582-1588.
15. Collin-Osdoby P, (1994) Role of vascular endothelial cells in bone biology. J Cell Biochem 55: 304-309.
16. Decker B, Bartels H, Decker S, (1995) Relationships between endothelial cells, pericytes, and osteoblasts during bone formation in the sheep femur following implantation of tricalciumphosphate-ceramic. Anat Rec 242: 310-320.
17. Ferguson C, Alpern E, Miclau T, Helms JA, (1999) Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 87: 57-66.
18. Young S, Kretlow JD, Nguyen C, Bashoura AG, Baggett LS, et al. (2008) Microcomputed tomography characterization of neovascularization in bone tissue engineering applications. Tissue Eng Part B Rev 14: 295-306.
19. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
20. Luttun A, Carmeliet G, Carmeliet P, (2002) Vascular progenitors: from biology to treatment. Trends Cardiovasc Med 12: 88-96.
21. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, et al. (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97: 3422-3427.
22. Shirota T, He H, Yasui H, Matsuda T, (2003) Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng 9: 127-136.
23. Atesok K, Li R, Stewart DJ, Schemitsch EH, (2010) Endothelial progenitor cells promote fracture healing in a segmental bone defect model. J Orthop Res 28: 1007-1014.
24. Seebach C, Henrich D, Kahling C, Wilhelm K, Tami AE, et al. (2010) Endothelial progenitor cells and mesenchymal stem cells seeded onto beta-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats. Tissue Eng Part A 16: 1961-1970.
25. Block MS, Achong R, (2006) Bone morphogenetic protein for sinus augmentation. Atlas Oral Maxillofac Surg Clin North Am 14: 99-105.
26. Holleville N, Quilhac A, Bontoux M, Monsoro-Burq AH, (2003) BMP signals regulate Dlx5 during early avian skull development. Dev Biol 257: 177-189.
27. Urist MR, (1965) Bone: formation by autoinduction. Science 150: 893-899.
28. Raida M, Heymann AC, Gunther C, Niederwieser D, (2006) Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells. Int J Mol Med 18: 735-739.
29. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, et al. (2002) Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84: 2123-2134.
30. Burkus JK, Transfeldt EE, Kitchel SH, Watkins RG, Balderston RA, (2002) Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976) 27: 2396-2408.
31. Vaccaro AR, Anderson DG, Patel T, Fischgrund J, Truumees E, et al. (2005) Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine (Phila Pa 1976) 30: 2709-2716.
32. Swiontkowski MF, Aro HT, Donell S, Esterhai JL, Goulet J, et al. (2006) Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am 88: 1258-1265.
33. Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, et al. (2006) Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 88: 1431-1441.
34. Gautschi OP, Frey SP, Zellweger R, (2007) Bone morphogenetic proteins in clinical applications. ANZ J Surg 77: 626-631.
35. Park Y, DziakR, Genco R, Swihart MT, Periopanayagam H (2010) Calcium Sulfate Based Nanoparticles; patent US, editor.USA.
36. Park YB, Mohan K, Al-Sanousi A, Almaghrabi B, Genco RJ, et al. (2011) Synthesis and characterization of nanocrystalline calcium sulfate for use in osseous regeneration. Biomed Mater 6: 055007.
37. Salvadori B, Capitani G, Mellini M, Dei L, (2006) A novel method to prepare inorganic water-soluble nanocrystals. J Colloid Interface Sci 298: 487-490.
38. He X, Dziak R, Mao K, Genco R, Swithart M, et al. (2013) Integration of a novel injectable nano calcium sulfate/alginate scaffold and BMP2 gene-modified mesenchymal stem cells for bone regeneration. Tissue Eng Part A 19: 508-518.
39. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
40. Yang N, Li D, Jiao P, Chen B, Yao S, et al. (2011) The characteristics of endothelial progenitor cells derived from mononuclear cells of rat bone marrow in different culture conditions. Cytotechnology 63: 217-226.
41. Tian F, Liang PH, Li LY, (2009) Inhibition of endothelial progenitor cell differentiation by VEGI. Blood 113: 5352-5360.
42. He X, Dziak R, Mao K, Genco R, Swithart M, et al. (2012) Integration of a Novel Injectable Nano Calcium Sulfate/Alginate Scaffold and BMP2 Gene-Modified Mesenchymal Stem Cells for Bone Regeneration. Tissue Eng Part A.
43. Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, et al. (2003) In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 18: 705-715.
44. Yang S, Li YP, (2007) RGS12 is essential for RANKL-evoked signaling for terminal differentiation of osteoclasts in vitro. Journal of Bone and Mineral Research 22: 45-54.
45. Yang S, Wang C, (2012) The intraflagellar transport protein IFT80 is required for cilia formation and osteogenesis. Bone 51: 407-417.
46. Yang S, Li YP, (2007) RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation. Genes Dev 21: 1803-1816.
47. Schmitz JP, Hollinger JO (1986) The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res: 299-308.
48. Dezawa M, Ishikawa H, Itokazu Y, Yoshihara T, Hoshino M, et al. (2005) Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309: 314-317.
49. Bessa PC, Casal M, Reis RL, (2008) Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2: 81-96.
50. Granero-Molto F, Weis JA, Longobardi L, Spagnoli A, (2008) Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opin Biol Ther 8: 255-268.
51. Quarles LD, (2012) Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol 8: 276-286.
52. Stoller MD, Murali S, Quarles N, Zhu Y, Potts JR, et al. (2012) Activated graphene as a cathode material for Li-ion hybrid supercapacitors. Phys Chem Chem Phys 14: 3388-3391.
53. McCarty RC, Gronthos S, Zannettino AC, Foster BK, Xian CJ, (2009) Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol 219: 324-333.
54. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012.
55. Walter DH, Dimmeler S, (2002) Endothelial progenitor cells: regulation and contribution to adult neovascularization. Herz 27: 579-588.
56. Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii S, (2003) VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 101: 168-172.
57. Jiang M, Wang B, Wang C, He B, Fan H, et al. (2008) Angiogenesis by transplantation of HIF-1 alpha modified EPCs into ischemic limbs. J Cell Biochem 103: 321-334.
58. Stein A, Montens HP, Steppich B, Busch G, Brandl R, et al. (2008) Circulating endothelial progenitor cells decrease in patients after endarterectomy. J Vasc Surg 48: 1217-1222.
59. Kim J, Kim IS, Cho TH, Lee KB, Hwang SJ, et al. (2007) Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 28: 1830-1837.
60. Peterson B, Zhang J, Iglesias R, Kabo M, Hedrick M, et al. (2005) Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 11: 120-129.
61. Nomi M, Atala A, Coppi PD, Soker S, (2002) Principals of neovascularization for tissue engineering. Mol Aspects Med 23: 463-483.
62. Kaigler D, Krebsbach PH, Wang Z, West ER, Horger K, et al. (2006) Transplanted endothelial cells enhance orthotopic bone regeneration. J Dent Res 85: 633-637.
63. Usami K, Mizuno H, Okada K, Narita Y, Aoki M, et al. (2009) Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation. J Biomed Mater Res A 90: 730-741.
64. Seebach C, Henrich D, Wilhelm K, Barker JH, Marzi I, (2012) Endothelial progenitor cells improve directly and indirectly early vascularization of mesenchymal stem cell-driven bone regeneration in a critical bone defect in rats. Cell Transplant 21: 1667-1677.
65. Young PP, Hofling AA, Sands MS, (2002) VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. Proc Natl Acad Sci U S A 99: 11951-11956.
66. Matsubara H, Hogan DE, Morgan EF, Mortlock DP, Einhorn TA, et al. (2012) Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis. Bone 51: 168-180.